High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients

Amplification of the fibroblast growth factor receptor 1 (FGFR1) is believed to predict response to FGFR inhibitors. The aim of this study was to investigate the frequency and the prognostic impact of FGFR1 amplification in patients with resected esophageal squamous cell carcinoma (ESCC) by using fl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Song, Qi, Liu, Yalan, Jiang, Dongxian, Wang, Haixing, Huang, Jie, Xu, Yifan, Sujie, Akesu, Zeng, Haiying, Xu, Chen, Hou, Yingyong
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650361/
https://ncbi.nlm.nih.gov/pubmed/29088806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20215
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars